Fred Hassan - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Director

Mr. Fred Hassan is Director of Amgen Inc. Mr. Fred Hassan was Partner and Managing Director at Warburg Pincus LLC, a global private equity investment institution, since 2011 and, prior to that, served as Senior Advisor from 2009 to 2010. Mr. Hassan was Chairman of the Board and Chief Executive Officer of ScheringPlough Corporationrationration from 2003 to 2009. Prior to this, Mr. Hassan was Chairman, President and Chief Executive Officer of Pharmacia Corporationrationration, from 2001 to 2003. Before assuming these roles, he had served as President and Chief Executive Officer of Pharmacia Corporationrationration from its creation in 2000 as a result of the merger of Pharmacia Upjohn, Inc. with Monsanto Company. He was President and Chief Executive Officer of Pharmacia Upjohn, Inc. beginning in 1997. Mr. Hassan previously held senior positions with Wyeth, including that of Executive Vice President with responsibility for its pharmaceutical and medical products businesses, and served as a member of the board from 1995 to 1997. Prior to that, Mr. Hassan held various roles at Sandoz Pharmaceuticals and headed its U.S. pharmaceuticals businesses.
Age: 70  Director Since 2015      
805 447-1010  www.amgen.com

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Christopher CoughlinAllergan plc
2016
William MontagueEndo International plc
2009
Louis DrapeauBio Rad Laboratories Inc
2007
James FarrellAbbott Laboratories
2006
Sharad MansukaniEndo International plc
2017
William SpenglerEndo International plc
2008
Christopher BodineAllergan plc
2013
William YoungVertex Pharmaceuticals Incorpor
2014
Ronald TaylorAllergan plc
2013
John StrattonAbbott Laboratories
2017
Ron TaylorAllergan plc
2013
Edward LiddyAbbott Laboratories
2010
Samuel ScottAbbott Laboratories
2007
Roxanne AustinAbbott Laboratories
2000
Alice SchwartzBio Rad Laboratories Inc
1967
Fred WeissAllergan plc
2013
Peter McDonnellAllergan plc
2015
Jill SmithEndo International plc
2012
Phebe NovakovicAbbott Laboratories
2010
Patrick OSullivanAllergan plc
2013
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Transaction History Now
   

Transaction History

View history of all your transactions and understand their impact on performance
Hide  View All  NextLaunch Transaction History
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators